Pantoprazole Gastro Resistant & Levosulpiride Sustained Release Capsules – Zentro LS Capsules

ZENTRO LS Capsules
Composition:- Pantoprazole Sodium (EC) 40 mg + Levosulpiride (SR) 75 mg.

ZENTRO LS – Pantoprazole Gastro-Resistant & Levosulpiride Sustained Release Capsules combination of Pantoprazole, a proton pump inhibitor (PPI), reduces gastric acid secretion by inhibiting the H+/K+ ATPase enzyme, treats GERD, and aids in healing peptic ulcers and esophageal damage caused by excess acid and Levosulpiride, a prokinetic agent, provides dual action by reducing stomach acid and improving gastrointestinal motility. It is highly effective in managing acid reflux, gastritis, and functional dyspepsia.

Marketed by: Wonne International Pvt. Ltd.

Key Points of Pantoprazole Gastro Resistant & Levosulpiride Sustained Release Capsules – Zentro LS Capsules

• Dual Action Formula – Pantoprazole reduces stomach acid while Levosulpiride enhances gastric motility for better digestion
• Effective GERD Management – Provides relief from symptoms associated with GERD like acid reflux, heartburn, and regurgitation
• Improves Gastric Healing – Helps heal peptic and gastric ulcers by reducing acid secretion, and Levosulpiride’s prokinetic action helps manage nausea associated with acid reflux.

• Gastroenterologists
• General Physicians
• Healthcare practitioner

Disclaimer: To be used under medical supervision only. Not intended for general public promotion. This content is meant for registered healthcare professionals only.